Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

AI & ML in Clinical Trials: Fundamentals, Applications, and Regulatory Aspects Scheduled for November 5, 2026

globenewswire.com
RDNT The article mentions ResearchAndMarkets.com as a provider of market research reports and data, and that they have added a new training course to their offering. The mention is informational and does not express a positive or negative view on the company's stock performance. AI Dedalus Healthcare is mentioned as the employer of a featured course speaker, Zuzanna Kwade. The article does not provide any sentiment or information about Dedalus Healthcare's stock performance or business operations.

AI & ML in Clinical Trials: Fundamentals, Applications, and Regulatory Aspects Scheduled for November 5, 2026 Dublin, Sept. 16, 2026 (GLOBE NEWSWIRE) -- "AI & ML in Clinical Trials: Fundamentals, Applications, and Regulatory Aspects (Nov 5, 2026)" has been added to ResearchAndMarkets.com's offering.

The AI & ML in Clinical Trials: Fundamentals, Applications, and Regulatory Aspects training course, delivered by IPI Academy, will take place online on November 5, 2026, from 09:00 to 17:00 GMT. The one-day programme examines Artificial Intelligence (AI) and Machine Learning (ML) applications in clinical trials alongside regulatory and ethical considerations relevant to their use in a highly regulated environment.

Key Event Facts

Course: AI & ML in Clinical Trials: Fundamentals, Applications, and Regulatory Aspects

Date: November 5, 2026

Time: 09:00–17:00 GMT

Format: Online event

Duration: 1 day

Focus: AI and ML fundamentals, clinical trial applications, regulatory frameworks and ethical considerations

CPD: 6 hours

The course provides an overview of AI and ML and focuses on how these technologies are applied in clinical trials. Topics include optimizing trial efficiency, predicting patient outcomes and supporting adaptive trial designs. The programme also examines the regulatory landscape for AI in clinical trials, including the EU AI Act and related regulatory initiatives, alongside ethical aspects and the integration and future directions of these technologies.

Why You Should Attend

The training is relevant to professional responsibilities involving clinical research, clinical operations, data management, regulatory and compliance functions. Its combination of AI and ML applications with regulatory and ethical considerations provides a structured framework for understanding the technologies and the responsibilities associated with their implementation in clinical trials.

Who Should Attend

Featured Course Speaker

Zuzanna Kwade, Software Clinical Evaluation Lead, Dedalus Healthcare. She holds a PhD in Biochemistry and has 15 years of experience in clinical and medical research. She has co-authored white papers on regulatory aspects of clinical research and clinical evaluation and has been involved in Clinical Evaluations according to MEDDEV 2.7.1 (Rev.4) for multiple devices. She also represented COCIR in the European Union Task Force on clinical evaluation of software and co-authored MDCG2020-1 guidance on clinical evaluation of MDSW.

The AI & ML in Clinical Trials: Fundamentals, Applications, and Regulatory Aspects course takes place on November 5, 2026. Professionals seeking to develop their understanding of AI and ML applications, regulatory considerations and ethical aspects in clinical trials can review the programme and register your interest through Research and Markets.

For more information about this training visit https://www.researchandmarkets.com/r/sdxxht

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.